Is it necessary to deplete the lymphokine activated killers’ populations of CD4+CD25+ lymphocytes? Regulatory Foxp3-positive T cells within lymphokine activated killers-Reference-Cited by-同舟云学术

Is it necessary to deplete the lymphokine activated killers’ populations of CD4+CD25+ lymphocytes? Regulatory Foxp3-positive T cells within lymphokine activated killers

Published:2010-07 Issue:6 Volume:64 Page:379-385
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Chikileva Irina Olegovna,Shubina Irina Z.,Baronzio Gianfranco,Kiselevsky Mikhail V.

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference41 articles.

1. Adoptive immunotherapy of established pulmonary metastases with LAKs and recombinant interleukin-2;Mule;Science,1984

2. Ellis TM Laboratory correlates of adoptive immunotherapy with recombinant interleukin-2 and lymphokine-activated killer cells in humans;Boldt;Cancer Res,1988

3. RB A new approach to generating antitumor effectors for adoptive immunotherapy using human adherent lymphokine-activated killer cells;Melder;Cancer Res,1988

4. Dendritic cells for NK/LAK activation: rationale for multicellular immunotherapy in neuroblastoma patients;Valteau-Couanet;Blood,2002

5. Shubina IZ, Lebedinskaya OV, Chalturina EO, Chikileva IO, Kiselevsky MV. Natural killer cells. Lymphokine-activated killers. In: Kiselevsky MV, editor. Atlas Effectors of Anti-Tumor Immunity. Springer; 2008. p. 45–65.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breast Cancer Cells Induce a Pro-inflammatory Response to Mitigate Immune Mediation in a 3D Culture Model;Anticancer Research;2020-10-27

2. Novel Strategy of Cancer Immunotherapy: Spiraling Up;Cancer Immunology;2020-09-25

3. Establishment of a heterotypic 3D culture system to evaluate the interaction of TREG lymphocytes and NK cells with breast cancer;Journal of Immunological Methods;2015-11

4. Adoptive Immunotherapy of Malignant Effusions;Malignant Effusions;2012